Allworth Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.08K | Hold |
10,005
| – | – | ﹤0.01% | 2935 |
|
|
2025
Q1 | $4.99K | Hold |
10,005
| – | – | ﹤0.01% | 2755 |
|
|
2024
Q4 | $6.75K | Sell |
10,005
-4,750
| -32% | -$3.21K | ﹤0.01% | 2613 |
|
|
2024
Q3 | $13.4K | Buy |
14,755
+10,000
| +210% | +$9.05K | ﹤0.01% | 2127 |
|
|
2024
Q2 | $4.76K | Hold |
4,755
| – | – | ﹤0.01% | 2551 |
|
|
2024
Q1 | $7.04K | Buy |
4,755
+5
| +0.1% | +$7 | ﹤0.01% | 2258 |
|
|
2023
Q4 | $5.18K | Hold |
4,750
| – | – | ﹤0.01% | 2262 |
|
|
2023
Q3 | $5.61K | Hold |
4,750
| – | – | ﹤0.01% | 2057 |
|
|
2023
Q2 | $6.7K | Hold |
4,750
| – | – | ﹤0.01% | 1989 |
|
|
2023
Q1 | $7.13K | Hold |
4,750
| – | – | ﹤0.01% | 1909 |
|
|
2022
Q4 | $5.56K | Hold |
4,750
| – | – | ﹤0.01% | 1857 |
|
|
2022
Q3 | $5K | Hold |
4,750
| – | – | ﹤0.01% | 1884 |
|
|
2022
Q2 | $8K | Hold |
4,750
| – | – | ﹤0.01% | 1634 |
|
|
2022
Q1 | $7K | Hold |
4,750
| – | – | ﹤0.01% | 1567 |
|
|
2021
Q4 | $12K | Hold |
4,750
| – | – | ﹤0.01% | 1324 |
|
|
2021
Q3 | $12K | Hold |
4,750
| – | – | ﹤0.01% | 1227 |
|
|
2021
Q2 | $14K | Buy |
+4,750
| New | +$14K | ﹤0.01% | 945 |
|